Siddharth Kusumakar is a partner at Powell Gilbert LLP (www.powellgilbert.com). Siddharth specializes in multi-jurisdictional patent litigation in the pharmaceutical, biotechnology and medical devices fields, and has considerable experience in coordinating pan-European litigation strategies.
As a UPC legal representative, he is currently acting in some of the first cases to be brought before the new Court and appeared in the first preliminary injunction hearing to be conducted in English. Siddharth has represented clients in litigation before the UK Patents Court, Court of Appeal and Supreme Court as well as in European Patent Office proceedings. He has successfully acted for clients in some of the most high-profile patent cases to come before the UK courts in recent years, including the landmark UK Supreme Court decisions in Warner-Lambert v Actavis and Regeneron v Kymab (in relation to the law of sufficiency and the infringement of second medical use patents), as well as cases shaping the current UK landscape on the availability of injunctions where the public interest is engaged.
Before qualifying as a solicitor advocate, Siddharth graduated from McGill University (BSc microbiology and immunology) and Imperial College London (MSc immunology).